Hyderabad: As the Drug Controller General of India (DCGI) has given its approval for ‘restricted use’ of the city-based Bharat Biotech’s Covaxin, GMR Hyderabad International Airport has put its best foot forward to transport the life-saving vaccine to global customers.
GMR Hyderabad International Airport Limited and GMR Hyderabad Air Cargo (GMR-HYD) have signed a Memorandum of Understanding (MoU) with the Dubai Airport, which is a major transit hub in West Asia, to build an exclusive vaccine air freight corridor, said a press release.
Known as ‘HYDXB-VAXCOR’ (‘Hyderabad to Dubai global Vaccine Corridor), the MoU will facilitate using each other’s facilities for a seamless moment of Covid-19 vaccines.
“The Partnership also entails Technology Collaboration, under which both the entities will explore and work together on an Integrated IT Solution that will provide End-to-End Visibility including Shipment Temperature and Status Tracking… during its onwards journey to various global destinations,” added the press release.
Besides Bharat Biotech, another two Hyderabad-based vaccine makers Hetero Biopharma and Biological E Limited are in the global vaccine race making GMR Hyderabad, which is the only international airport in Telangana, as the centrepiece of global Covid-19 vaccine distribution network.
While Hetero has signed an agreement with the Russian Direct Investment Fund (RDIF) to manufacture 10 crore Sputnik V vaccines per annum, Biological E Limited’s vaccine is undergoing trails.